Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Koh

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Ophthalmology|April 16, 2019
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
Ophthalmology|November 25, 2019
ReplyPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
Ophthalmology. Retina|February 8, 2026
Potential 20-week Faricimab Dosing in Wet Age-Related Macular DegenerationAude Ambresin, Varun Chaudhary, Richard Gale, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|September 21, 2020
Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus GuidelinesJay Chhablani, Kelvin Wong, Gavin S Tan, et al.
Retina (Philadelphia, Pa.)|March 20, 2012
EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathyAdrian Koh, Won Ki Lee, Lee-Jen Chen, et al.
European Journal of Ophthalmology|June 27, 2019
First-line treatment algorithm and guidelines in center-involving diabetic macular edemaLaurent Kodjikian, David Bellocq, Francesco Bandello, et al.
JAMA Ophthalmology|October 7, 2017
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical TrialAdrian Koh, Timothy Y Y Lai, Kanji Takahashi, et al.
Ophthalmology|February 29, 2020
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular DegenerationQuan Dong Nguyen, Arup Das, Diana V Do, et al.
Ophthalmology|May 19, 2015
The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular EdemaTatsuro Ishibashi, Xiaoxin Li, Adrian Koh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 11, 2020
A Lesson from Plants: High-Speed Soft Robotic ActuatorsRichard Baumgartner, Alexander Kogler, Josef M Stadlbauer, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Ophthalmology|April 16, 2019
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
Ophthalmology|November 25, 2019
ReplyPravin U Dugel, Adrian Koh, Yuichiro Ogura, et al.
Ophthalmology. Retina|February 8, 2026
Potential 20-week Faricimab Dosing in Wet Age-Related Macular DegenerationAude Ambresin, Varun Chaudhary, Richard Gale, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|September 21, 2020
Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus GuidelinesJay Chhablani, Kelvin Wong, Gavin S Tan, et al.
Retina (Philadelphia, Pa.)|March 20, 2012
EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathyAdrian Koh, Won Ki Lee, Lee-Jen Chen, et al.
European Journal of Ophthalmology|June 27, 2019
First-line treatment algorithm and guidelines in center-involving diabetic macular edemaLaurent Kodjikian, David Bellocq, Francesco Bandello, et al.
JAMA Ophthalmology|October 7, 2017
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical TrialAdrian Koh, Timothy Y Y Lai, Kanji Takahashi, et al.
Ophthalmology|February 29, 2020
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular DegenerationQuan Dong Nguyen, Arup Das, Diana V Do, et al.
Ophthalmology|May 19, 2015
The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular EdemaTatsuro Ishibashi, Xiaoxin Li, Adrian Koh, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 11, 2020
A Lesson from Plants: High-Speed Soft Robotic ActuatorsRichard Baumgartner, Alexander Kogler, Josef M Stadlbauer, et al.
Pageof 6